hypusine has been researched along with ciclopirox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alliessi Gandolfi, D; Hanauske-Abel, HM; Hoque, M; Mathews, MB; Palumbo, P; Park, MH; Pe'ery, T; Saxena, D | 1 |
| Bouvet, M; Fujimura, K; Kaushal, S; Kelber, JA; Klemke, RL; Lowy, AM; Metildi, C; Strnadel, J; Wright, T | 1 |
2 other study(ies) available for hypusine and ciclopirox
| Article | Year |
|---|---|
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Topics: Anti-HIV Agents; Ciclopirox; Deferiprone; Enzyme Inhibitors; Eukaryotic Translation Initiation Factor 5A; Gene Expression; HIV-1; Humans; Leukocytes, Mononuclear; Lysine; Mixed Function Oxygenases; Peptide Initiation Factors; Pyridones; RNA-Binding Proteins; Virus Replication | 2009 |
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Deoxycytidine; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Humans; Lysine; Mice; Pancreatic Neoplasms; Peptide Initiation Factors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyridones; ras Proteins; RNA-Binding Proteins | 2014 |